Publikationen in Zusammenarbeit mit Forschern von Instituto Valenciano de Oncologia (73)

2024

  1. Efficacy and safety of cemiplimab in the treatment of advanced cutaneous squamous cell carcinoma: A multicentre real-world retrospective study from Spain and systematic review of the published data

    Journal of the European Academy of Dermatology and Venereology

  2. Longitudinal Study of Different Progression Patterns in High-Risk Cutaneous Squamous Cell Carcinoma

    Actas Dermo-Sifiliograficas, Vol. 115, Núm. 7, pp. 670-678

  3. Main Types of Cysts in Dermatopathology: Part 1

    Revista Espanola de Patologia, Vol. 57, Núm. 1, pp. 27-41

  4. Main Types of Cysts in Dermatopathology: Part 2

    Revista Espanola de Patologia, Vol. 57, Núm. 2, pp. 97-110

  5. Morphological MRI features as prognostic indicators in brain metastases

    Cancer Imaging, Vol. 24, Núm. 1

  6. Repeated pancreatic resection for pancreatic metastases from renal cell Carcinoma: A Spanish multicenter study (PANMEKID)

    Surgical Oncology, Vol. 52

  7. Safety profile of trastuzumab deruxtecan in advanced breast cancer: Expert opinion on adverse event management

    Clinical and Translational Oncology, Vol. 26, Núm. 7, pp. 1539-1548

  8. Sentinel lymph node biopsy versus observation in high-risk cutaneous squamous cell carcinoma in immunosuppressed and immunocompetent patients: An inverse probability of treatment weighting study

    Journal of the European Academy of Dermatology and Venereology, Vol. 38, Núm. 8, pp. 1588-1598

  9. Status of head and neck brachytherapy in Spain in 2022

    Clinical and Translational Oncology, Vol. 26, Núm. 2, pp. 456-460

  10. The S-REAL study: Spanish real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy

    Clinical and Translational Oncology, Vol. 26, Núm. 7, pp. 1779-1789

  11. Volumetric analysis: Rethinking brain metastases response assessment

    Neuro-Oncology Advances, Vol. 6, Núm. 1

2023

  1. A comprehensive dataset of annotated brain metastasis MR images with clinical and radiomic data

    Scientific data, Vol. 10, Núm. 1, pp. 208

  2. Growth exponents reflect evolutionary processes and treatment response in brain metastases

    npj Systems Biology and Applications, Vol. 9, Núm. 1

  3. Melanoma arising in plaque-type blue nevus and dermal melanocytosis: Diagnostic and prognostic value of BAP1

    Actas Dermo-Sifiliograficas, Vol. 114, Núm. 7, pp. 636-641

  4. NLRP3 inflammasome activation and symptom burden in KRAS-mutated CMML patients is reverted by IL-1 blocking therapy

    Cell Reports Medicine, Vol. 4, Núm. 12

  5. Prognostic factors for satellitosis or in-transit metastasis in cutaneous squamous cell carcinoma: A multicentric cohort study

    Journal of the American Academy of Dermatology, Vol. 89, Núm. 1, pp. 119-127

  6. Real-World Experience with Vismodegib on Advanced and Multiple BCCs: Data from the RELIVIS Study

    Dermatology (Basel, Switzerland), Vol. 239, Núm. 5, pp. 685-693

  7. Results in mediastinal lymph node staging of surgical lung cancer: Data from the prospective cohort of the Spanish Video-Assisted Thoracic Surgery Group

    Cirugia Espanola, Vol. 101, Núm. 6, pp. 408-416

  8. Selection of Quality Indicators for the Certification of Dermato-Oncology Units: The CUDERMA Project Delphi Consensus Study

    Actas Dermo-Sifiliograficas, Vol. 114, Núm. 7, pp. 587-605

  9. The Management of Metastatic Spinal Cord Compression in Routine Clinical Practice

    Cancers, Vol. 15, Núm. 10